We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pain Detection and Interception in Neonates

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00447824
Recruitment Status : Unknown
Verified March 2007 by Sorlandet Hospital HF.
Recruitment status was:  Recruiting
First Posted : March 15, 2007
Last Update Posted : March 15, 2007
Helse sor
Information provided by:
Sorlandet Hospital HF

Brief Summary:


  1. May the introduction of NIDCAP during blood sample reduced pain in neonates during blood sample
  2. Compare the effect of venous and capillary blood sample method

Condition or disease Intervention/treatment
Pain Detection Pain Intervention Procedure: Introduction of better conditions during blood sampling

Detailed Description:
introducing the: Newborn Individualized Developmental Care and Assessment Program

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 160 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Pain Detection and Interception in Neonates During Blood Sampling
Study Start Date : March 2007
Estimated Study Completion Date : November 2009

Primary Outcome Measures :
  1. value of Premature Infant Pain Profile
  2. Heart rate
  3. Saturation
  4. Skin conductance changes

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   31 Weeks to 36 Weeks   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Born gestation age 31-36

Exclusion Criteria:

  • Infection, respiratory distress

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00447824

Contact: Knut G Hernes, Dr +(47) 957 99999 drhernes@gmail.com

Sorlandet Hospital SSHF Recruiting
Kristiansand, Vest Agder, Norway, 4600
Sub-Investigator: Liv Normann         
Sub-Investigator: Randi S Dahl         
Sponsors and Collaborators
Sorlandet Hospital HF
Helse sor
Study Chair: Knut G Hernes, Dr

ClinicalTrials.gov Identifier: NCT00447824     History of Changes
Other Study ID Numbers: S-06471a
First Posted: March 15, 2007    Key Record Dates
Last Update Posted: March 15, 2007
Last Verified: March 2007

Keywords provided by Sorlandet Hospital HF: